Taiho Oncology

Taiho Oncology is a pharmaceutical company engaged in the discovery and development of cancer treatments. It provides an oral oncology pipeline consisting of both antimetabolic and selectively targeted agents.

Employee Rating

3
TypeSubsidiary
HQSingapore, SG
Founded2002
Websitetaihooncology.com
Cybersecurity ratingAMore
Taiho Oncology was founded in 2002 and is headquartered in Singapore, SG

Viewing summary data as a guest

Sign up for free to see all data
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Taiho Oncology

Masayuki Kobayashi

Masayuki Kobayashi

Director
Tim Whitten

Tim Whitten

President & CEO, Director
Martin J. Birkhofer

Martin J. Birkhofer

Senior Vice President and Chief Medical Officer
Michael Schick

Michael Schick

Senior Vice President, Chief Commercial Officer
Chris Jewell

Chris Jewell

Senior Vice President and General Counsel
Show more

Taiho Oncology Office Locations

Taiho Oncology has offices in Singapore, Menlo Park, Princeton, Oakville and in 2 other locations
Singapore, SG (HQ)
390 Havelock Rd
Oakville, CA
2010 Winston Park Dr #503
Chiyoda City, JP
1-chōme-4-10 Uchikanda
Birmingham, GB
Two, Snowhill
Menlo Park, CA, US
2420 Sand Hill Rd #203
Princeton, NJ, US
101 Carnegie Dr #101
Show all (7)

Taiho Oncology Financials and Metrics

Summary Metrics

Founding Date

2002

Taiho Oncology Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

Taiho Oncology Online and Social Media Presence

Embed Graph

Taiho Oncology News and Updates

NCCN Announces Projects to Study Oral Decitabine and Cedazuridine in Collaboration with Taiho Oncology

PLYMOUTH MEETING, Pa., April 14, 2021 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced that three projects have been selected to study oral decitabine (35 mg) and cedazuridine (100 mg). The NCCN ORP convened a Scientific...

Taiho Oncology To Present Phase 2 Data for Futibatinib (TAS-120) in Advanced Intrahepatic Cholangiocarcinoma at Virtual AACR Annual Meeting 2021

PRINCETON, N.J., April 2, 2021 /PRNewswire/ -- Taiho Oncology, Inc. today announced that Phase 2 clinical data, along with preclinical and Phase 1 clinical data for futibatinib (TAS-120) will be presented during the American Association for Cancer Research (AACR) Annual Meeting 2021 Week...

NCCN Oncology Research Program, with Taiho Oncology, to Explore New Research into Oral Medication Targeting Tumor Suppression Genes

PLYMOUTH MEETING, Pa., Sept. 1, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced plans to develop a program to scientifically evaluate and facilitate clinical trials on the efficacy of decitabine and cedazuridine. This...

Taiho Oncology Announces Presentation of Data for Futibatinib in Advanced Intrahepatic Cholangiocarcinoma at 2020 ASCO Meeting

PRINCETON, N.J., May 31, 2020 /PRNewswire/ -- Taiho Oncology, Inc. today announced efficacy and safety results of an interim analysis of FOENIX-CCA2, a single-arm multicenter Phase 2 study evaluating futibatinib (TAS-120) in patients with intrahepatic cholangiocarcinoma (iCCA) harboring...

Taiho Oncology Frequently Asked Questions

  • When was Taiho Oncology founded?

    Taiho Oncology was founded in 2002.

  • Who are Taiho Oncology key executives?

    Taiho Oncology's key executives are Masayuki Kobayashi, Tim Whitten and Martin J. Birkhofer.

  • How many employees does Taiho Oncology have?

    Taiho Oncology has 266 employees.

  • Who are Taiho Oncology competitors?

    Competitors of Taiho Oncology include Kyowa Kirin, PLIVA and Jiangsu Hansoh Pharmaceutical Group.

  • Where is Taiho Oncology headquarters?

    Taiho Oncology headquarters is located at 390 Havelock Rd, Singapore.

  • Where are Taiho Oncology offices?

    Taiho Oncology has offices in Singapore, Menlo Park, Princeton, Oakville and in 2 other locations.

  • How many offices does Taiho Oncology have?

    Taiho Oncology has 7 offices.